Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis

  • Adam SchmitzEmail author
  • Paul Haste
  • Matthew S. Johnson
Original Article



Transjugular intrahepatic portosystemic shunt (TIPS) creation is most commonly performed for patients with refractory ascites or variceal hemorrhage. While TIPS have also been created prior to planned abdominal operation to decrease morbidity related to portal hypertension, there are limited data supporting its effectiveness in that indication. The goal of this study was to determine if preoperative TIPS creation allows for successful abdominal operation with limited morbidity.


A retrospective review of records of 22 consecutive patients who underwent TIPS creation for the specific indication of improving surgical candidacy, between 2011 and 2016, was performed. Clinical and serologic data were obtained for 21 patients (one patient was excluded since she was completely lost to follow-up after TIPS creation). The primary endpoint was whether patients underwent planned abdominal operation following TIPS. Operative outcomes and reasons that patients failed to undergo planned operation were examined as secondary endpoints. The mean age was 56.4 ± 8.8 years and the mean Child-Pugh and Model for End-Stage Liver Disease (MELD) scores were 7.2 ± 1.5 and 11.9 ± 4.3, respectively.


TIPS creation was performed in all 21 patients with a 30-day mortality rate of 9.5%. Eleven patients (52.4%) subsequently underwent abdominal operation after which the 30-day postoperative mortality rate was 0%. One patient (9.1%) had major perioperative morbidity related to portal hypertension and presented with surgical wound dehiscence and infection requiring drain placement and antibiotic therapy.


In this population, TIPS allowed successful abdominal operation in the majority of patients, with 30-day TIPS mortality of 9.5%, no perioperative mortality, and 9.1% major postoperative morbidity attributable to portal hypertension.


Transjugular intrahepatic portosystemic shunt TIPS Surgery Portal hypertension 



Special thanks to the Department of Radiology and Imaging Sciences at Indiana University School of Medicine for aiding in the development of this study.

Authors’ Contribution

Adam Schmitz made substantial contributions to the design of this study, analyzed the data, and wrote and approved the final manuscript form. In addition, Mr. Schmitz agrees to be accountable for the information presented in this manuscript.

Dr. Paul Haste made substantial contributions to the design of this study, aided in the drafting process, and approved the final manuscript form. In addition, Dr. Haste agrees to be accountable for the information presented in this manuscript.

Dr. Matthew S. Johnson made substantial contributions to the design of this study, aided in the drafting process, and approved the final manuscript form. In addition, Dr. Johnson agrees to be accountable for the information presented in this manuscript.

Funding Information

This study was funded, in part, by Award Number T35HL110854 from the National Institutes of Health.

Compliance with Ethical Standards

Conflict of Interest

Dr. Johnson is a paid consultant to Cook Medical. The other authors declare that they have no conflict of interest.


  1. 1.
    Loffroy R, Favelier S, Pottecher P, Estivalet L, Genson PY, Gehin S, et al. Transjugular intrahepatic portosystemic shunt for acute variceal gastrointestinal bleeding: Indications, techniques and outcomes. Diagnostic and interventional imaging. 2015;96(7–8):745–55.CrossRefPubMedGoogle Scholar
  2. 2.
    de Goede B, Klitsie PJ, Lange JF, Metselaar HJ, Kazemier G. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review. Best practice & research Clinical gastroenterology. 2012;26(1):47–59.CrossRefGoogle Scholar
  3. 3.
    Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Annals of surgery. 2005;242(2):244–51.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    De Stefano F, Garcia CR, Gupta M, Marti F, Turcios L, Dugan A, et al. Outcomes in patients with portal hypertension undergoing gastrointestinal surgery: A propensity score matched analysis from the NSQIP dataset. The American Journal of Surgery. 2018.Google Scholar
  5. 5.
    Azoulay D, Buabse F, Damiano I, Smail A, Ichai P, Dannaoui M, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. Journal of the American College of Surgeons. 2001;193(1):46–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Fares N, Robic MA, Peron JM, Muscari F, Otal P, Suc B, et al. Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study. European journal of gastroenterology & hepatology. 2018;30(1):21–6.CrossRefGoogle Scholar
  7. 7.
    Vinet E, Perreault P, Bouchard L, Bernard D, Wassef R, Richard C, et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2006;20(6):401–4.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Corey KE, Kaplan LM. Obesity and liver disease: the epidemic of the twenty-first century. Clinics in liver disease. 2014;18(1):1–18.CrossRefPubMedGoogle Scholar
  9. 9.
    Kim JJ, Dasika NL, Yu E, Fontana RJ. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery. Journal of clinical gastroenterology. 2009;43(6):574–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World journal of hepatology. 2014;6(5):263–73.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    O'Leary JG, Yachimski PS, Friedman LS. Surgery in the patient with liver disease. Clinics in liver disease. 2009;13(2):211–31.CrossRefPubMedGoogle Scholar
  12. 12.
    Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk Factors for Mortality After Surgery in Patients With Cirrhosis. Gastroenterology. 2007;132(4):1261–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clinics in liver disease. 2012;16(1):133–46.CrossRefPubMedGoogle Scholar
  14. 14.
    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery. 2004;240(2):205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Smith MT, Rase B, Woods A, Trotter J, Gipson M, Kondo K, et al. Risk of hernia incarceration following transjugular intrahepatic portosystemic shunt placement. Journal of vascular and interventional radiology : JVIR. 2014;25(1):58–62.CrossRefPubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2019

Authors and Affiliations

  1. 1.Department of RadiologyIndiana University School of MedicineIndianapolisUSA
  2. 2.IndianapolisUSA

Personalised recommendations